Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Drug Market Has Gaps, FDA Tells Firms In Solicitation For ANDAs

Jun 29 2017

• By Derrick Gingery

priority button

Related Content

FDA's Generic Policy Initiative Includes Choose-Your-Own-Agenda Meeting

Jun 22 2017

Generic Industry Gets 267 Reasons From FDA To Pursue ANDA Development

Jun 28 2017

FDA Drug Pricing Policy Offers Short-Term PR Gain, More Long-Term Actual Benefit

Jun 28 2017

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

Mar 21 2016

Related Companies

Johnson & Johnson

Additional Topics

United States Pricing Debate FDA Generic Drugs Regulation BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window